For laboratory research only. Not for human consumption.Our comparison method ↗
Studio-style Deals on Peptides product visual for Ipamorelin

Vial comparison

Ipamorelin prices

Compare single-compound Ipamorelin research vials by labeled amount and pack count. Some suppliers shorten the name to Ipa, which is a recognized search alias in this index.

47suppliers represented
64source-linked listings
4strengths available

MATCH SIZE AND QUANTITY

Build your comparison.

Daily snapshot · inspect sources

Choose a labeled amount and selection to load matching prices.

GO BEYOND THE PRICE

Track it. Plan it. Inspect it.

Select a strength and selection above to view price history, save a price watch or add it to your basket.

DOCUMENTATION PASSPORTS

Reports and batch records

Search all batch records

Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.

Loading documentation records…

Listed amounts and selections

  • 2 mg1 supplier · Pack counts: 1
  • 5 mg18 suppliers · Pack counts: 1, 10
  • 10 mg36 suppliers · Pack counts: 1, 2, 3, 6, 10
  • 12 mg1 supplier · Pack counts: 1

Reported quantities in this family: 1, 2, 3, 6, 10. Counts and units must be matched to the exact listing.

How to compare Ipamorelin listings

The catalog includes 2 mg, 5 mg, 10 mg and 12 mg Ipamorelin vial labels, with both single-vial and multipack offers. Match the amount and count to compare equal selections. For unit pricing, divide the total price by the labeled milligrams across all included vials.

Check the full title when a listing uses Ipa or Ipamorelin. CJC-1295/Ipamorelin combinations and atomized-solution kits appear in separate groups. The presence of the alias does not establish a single-compound vial, and a combined blend weight cannot be assigned entirely to Ipamorelin.

Before opening an offer

  • Read beyond the Ipa abbreviation to confirm the listing contains Ipamorelin alone.
  • Keep CJC-1295/Ipamorelin recipes and solution kits separate from the vial offers on this page.
  • Compare the listed total price first; inspect any reported coupon and its conditions separately.

Single-vial price overview

Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.

Listed total prices before additional promotions or coupon estimates. Includes supplier captures and aggregator reports; capture dates do not confirm current vendor price or stock. Shipping and tax extra. Open the source before relying on a price.
StrengthSelectionLowest listed total pricePrice per mgSupplier countCompare
2 mg1 vial$9.34$4.671Compare
5 mg1 vial$19.24$3.8513Compare
10 mg1 vial$26.00$2.6035Compare
12 mg1 vial$21.99$1.831Compare

Suppliers with Ipamorelin listings

47 profiles
View 41 more supplier profiles

Sources and comparison limits

8 listings from direct supplier captures and 56 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.

Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.

Questions about this comparison

Does Ipa in a product title always identify a matching Ipamorelin vial?

No. Ipa is a recognized alias, but it can also appear in combination-product names. The full title, format and component list must support a single-compound vial match.

Are reported coupon estimates included in the Ipamorelin price ranking?

No. Ranking uses listed total prices or their calculated cost per labeled mg. Reported codes and estimates remain separate because eligibility, expiry and whether a code combines with another offer must be confirmed with the supplier.

Explore more vial listings

Browse all products

FROM PEPTIDES CALCULATOR

About Ipamorelin

Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile

Ipamorelin (NNC 26-0161) is a synthetic five-residue peptide developed by Novo Nordisk in the 1990s that triggers growth hormone release through the ghrelin receptor without the cortisol, ACTH or prolactin rise seen with earlier GHRPs. Human exposure comes from a 40-volunteer intravenous pharmacokinetic study and a 117-patient phase 2 trial run by Helsinn for post-operative ileus, which was safe but did not beat placebo, after which clinical development stopped. It has no approval anywhere, is prohibited by WADA, and in October 2024 the FDA's Pharmacy Compounding Advisory Committee voted 12 to 0 against adding either the free base or the acetate to the list of substances that may be compounded; it is nonetheless still prescribed off-label through compounding pharmacies and telehealth, usually at bedtime and often combined with the GHRH analog CJC-1295 without DAC.

Formula
C38 H49 N9 O5
Molar mass
711.9 g/mol
CAS number
170851-70-4
Amino acids
5

Research evidence described in the source

Animal

Selective secretagogue profile

The foundational study showed GH release with less ACTH/cortisol response in animal models.

Human

Early pharmacokinetic/pharmacodynamic work

Healthy-volunteer studies characterized concentration and GH response.

Human

Unsuccessful ileus development

Phase 2 programs did not show meaningful improvement over placebo and development stopped.

Limitations noted in the source

  • Short-term GH release is a biomarker, not evidence of body-composition or recovery benefit.
  • Long-term metabolic, neoplastic, and endocrine safety is not established for wellness use.
  • A calculator preset is a recorded research convention, not a recommendation or evidence of clinical benefit.
  • Identity, purity, sterility, and stability can vary substantially outside regulated manufacturing.
Publications and references linked by the source

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.